Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...
Zacks Investment Research on MSN
MRNA stock jumps on global submissions seeking nod for flu vaccine
Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 across the United States, European Union, Canada and Australia. These filings ...
Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...
CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's ...
The positive long-term data represents a significant milestone for Moderna as it works to diversify its revenue beyond COVID-19 vaccines and establish its mRNA platform as a viable cancer treatment ...
Add Yahoo as a preferred source to see more of our stories on Google. While the Food and Drug Administration approved the next round of COVID-19 vaccines, who's eligible to receive updated shots this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback